Atlas Venture Life Science Advisors as of June 30, 2026
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 7 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 37.1 | $327M | 2.8M | 114.67 | |
| Dyne Therapeutics Common Stock (DYN) | 17.1 | $151M | 6.8M | 22.21 | |
| Sionna Therapeutics Common Stock (SION) | 15.0 | $132M | 3.0M | 43.99 | |
| Kailera Therapeutics Common Stock | 12.9 | $114M | 5.2M | 22.03 | |
| Disc Medicine Common Stock (IRON) | 12.6 | $111M | 1.5M | 73.14 | |
| Q32 Bio Common Stock (QTTB) | 3.9 | $35M | 2.7M | 12.74 | |
| Korro Bio Common Stock (KRRO) | 1.4 | $13M | 963k | 13.18 |
